Table 6.
Baseline characteristics of the participants in the intervention group and control group
| Total | IG (n = 85) | CG (n = 86) | t/χ2 | P value | |
|---|---|---|---|---|---|
| Demographic, Mean (SD) | |||||
| Gender (Male/Female) | 97/74 | 42/43 | 55/31 | 3.682 | 0.055 |
| Age (years) | 55.1 (10.8) | 55.4 (9.7) | 54.7 (11.8) | −0.416 | 0.678 |
| BMI (Kg/m2) | 25.8 (3.8) | 25.9 (3.5) | 25.8 (4.1) | −0.255 | 0.799 |
| Indicators, Mean (SD) | |||||
| FPG (mmol/L) | 9.0 (2.6) | 9.2 (2.8) | 8.8 (2.4) | −0.954 | 0.342 |
| PPG (mmol/L) | 16.6 (4.4) | 16.8 (4.6) | 16.4 (4.3) | −0.599 | 0.550 |
| SBP (mmHg) | 132.3 (17.0) | 131.0 (16.1) | 134.3 (17.8) | 1.137 | 0.257 |
| DBP (mmHg) | 80.8 (11.8) | 79.8 (9.8) | 81.8 (13.5) | 1.034 | 0.303 |
| FPG control (%) | 48 (28.4) | 25 (29.8) | 23 (27.1) | 0.152 | 0.697 |
| PPG control (%) | 16 (9.6) | 10 (12.0) | 6 (7.2) | 1.107 | 0.293 |
| SBP control (%) | 90 (60.8) | 51 (68.0) | 39 (53.4) | 3.298 | 0.069 |
| DBP control (%) | 92 (63.4) | 50 (68.5) | 42 (58.3) | 1.613 | 0.204 |
| Total cholesterol (mg/l) | 4.7 (1.2) | 4.8 (1.2) | 4.7 (1.2) | −0.747 | 0.456 |
| Triglycerides (mg/l) | 1.9 (1.3) | 1.9 (1.3) | 1.9 (1.2) | 0.275 | 0.783 |
| HDL-C (mg/l) | 1.1 (0.3) | 1.1 (0.2) | 1.1 (0.3) | −1.062 | 0.290 |
| LDL-C (mg/l) | 3.0 (0.9) | 3.0 (0.9) | 2.9 (1.0) | −0.739 | 0.461 |
| HbAlC (%) | 9.2 (2.0) | 9.2 (2.0) | 9.1 (2.0) | −0.339 | 0.735 |
| Risk factors | |||||
| Hypertension (%) | 65 (39.6) | 32 (39.0) | 33 (40.2) | 0.025 | 0.873 |
| Dyslipidemia (%) | 96 (56.1) | 46 (54.1) | 50 (58.1) | 0.126 | 0.722 |
| Smoking (%) | 44 (25.7) | 23 (27.1) | 21 (24.4) | 0.156 | 0.693 |
| Drinking (%) | 58 (33.9) | 26 (30.6) | 32 (37.2) | 0.361 | 0.836 |
| Overweight (%) | 97 (58.1) | 50 (61.0) | 47 (55.3) | 0.553 | 0.457 |
| Pain (%) | 94 (55.3) | 41 (48.2) | 53 (62.4) | 3.427 | 0.064 |
| Anxiety (%) | 82 (48.2) | 43 (50.6) | 39 (45.9) | 0.377 | 0.539 |
| Hypoglycemic therapy (%) | 156 (94.0) | 80 (97.6) | 76 (90.5) | 2.534 | 0.111 |
| Medication way (%) | 3.058 | 0.217 | |||
| insulin | 80 (51.9) | 46 (57.5) | 34 (45.9) | ||
| Oral medication + insulin | 48 (31.2) | 20 (25.0) | 28 (37.8) | ||
| Oral medication | 26 (16.9) | 14 (17.5) | 12 (16.2) | ||
| Antihypertensive therapy (%) | 60 (35.1) | 31 (36.5) | 29 (33.7) | 0.672† | |
CG control group, IG intervention group, SD standard deviation, BMI body mass index, FPG fasting plasma glucose, PPG postprandial glucose, SBP systolic blood pressure, DBP diastolic blood pressure, HDL-C high density lipoprotein-c, LDL-C low density lipoprotein-c
†Fisher probabilities method